Mannkind

Welcome To The Mannkind HUB On AGORACOM Edit this title from the Fast Facts Section
Home Videos Research Press Release Q&A Discussion
Discussion Parent
Back     Next
Threads Posts
Re: Biodel's VIAject ultra rapid acting insulin
Mannkind
almost 12 years ago
0
in response to BobW's message

From their web-site: We now intend to study BIOD-123 in a Phase 2 clinical trial that we expect to begin in the third calendar quarter of 2012.

If successful, it is conceivable that it could be approved in a few years. Even if this is after Afrezza, it would make it harder for Afrezza to ramp up to its potential market share.

Back     Next
Please login to post a reply
BobW
City
NYC area, Long Island
Rank
Vice President
Activity Points
1080
Rating
Your Rating
Please Log In to Vote
Date Joined
08/19/2012
Social Links
Private Message
Mannkind
Stock Quotes
Symbol
MNKD
Exchange
NAZ
Shares
Industry
Technology & Medical
Website
Create a Post
Follow Hub
Disclaimer